Sec Form 4 Filing - RYAN STEPHEN J @ ALLERGAN INC - 2012-08-03

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person RYAN STEPHEN J 2. Issuer Name and Ticker or Trading Symbol ALLERGAN INC [ AGN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 2525 DUPONT DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 08/03/2012 (Street) IRVINE, CA92612 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/03/2012 M 5,000 A $ 36.85 53,451.819 D Common Stock 08/03/2012 M 5,000 A $ 45.885 58,451.819 D Common Stock 08/03/2012 M 5,000 A $ 36.49 63,451.819 D Common Stock 08/03/2012 S 15,000 D $ 86.5037 ( 1 ) 48,451.819 D Common Stock 08/06/2012 M 9,000 A $ 51.715 57,451.819 D Common Stock 08/06/2012 M 6,900 A $ 54.32 64,351.819 D Common Stock 08/06/2012 S 15,900 D $ 85.4672 ( 2 ) 48,451.819 D Common Stock 08/07/2012 M 4,500 A $ 54.32 52,951.819 D Common Stock 08/07/2012 M 11,400 A $ 46.66 64,351.819 D Common Stock 08/07/2012 S 15,900 D $ 85.3452 ( 3 ) 48,451.819 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Nonemployee Director Stock Option (Right to Buy) $ 36.85 08/03/2012 M 5,000 04/25/2004 04/24/2013 Common Stock 5,000 $ 0 0 D Nonemployee Director Stock Option (Right to Buy) $ 45.88 08/03/2012 M 5,000 04/28/2005 04/28/2014 Common Stock 5,000 $ 0 0 D Nonemployee Director Stock Option (Right to Buy) $ 36.49 08/03/2012 M 5,000 04/26/2006 04/26/2015 Common Stock 5,000 $ 0 0 D Nonemployee Director Stock Option (Right to Buy) $ 51.71 08/06/2012 M 9,000 05/02/2007 05/02/2016 Common Stock 9,000 $ 0 0 D Nonemployee Director Stock Option (Right to Buy) $ 54.32 08/06/2012 M 6,900 ( 4 ) 05/06/2018 Common Stock 6,900 $ 0 4,500 D Nonemployee Director Stock Option (Right to Buy) $ 54.32 08/07/2012 M 4,500 ( 4 ) 05/06/2018 Common Stock 4,500 $ 0 0 D Nonemployee Director Stock Option (Right to Buy) $ 46.66 08/07/2012 M 11,400 ( 5 ) 04/30/2019 Common Stock 11,400 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other RYAN STEPHEN J 2525 DUPONT DRIVE IRVINE, CA92612 X Signatures /s/ Matthew J. Maletta, Attorney-in-Fact for Stephen J. Ryan 08/07/2012 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.4375 to $86.5700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. ( 2 )The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.1500 to $85.6100, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. ( 3 )The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.0700 to $85.6700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. ( 4 )Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant. ( 5 )Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.